C9070 is a valid 2023 HCPCS Code that could be used to indicate Injection, tafasitamab-cxix, 2 mg for reimbursement purposes.
C9070 belongs to Other Medical Items or Services Type of Service and has been in effect since Jan 01, 2021.
Injection, tafasitamab-cxix
C9070 code information
| HCPCS code: | C9070 |
| Description: | INJECTION, TAFASITAMAB-CXIX, 2 MG |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Jan 01, 2021 |
| Termination Date: | HCPCS C9070 was terminated on Nov 30, -0001 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
F - AMBULATORY SURGICAL CENTER (FACILITY USAGE FOR SURGICAL SERVICES)
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to C9070